99 related articles for article (PubMed ID: 32380454)
1. Outcomes of Patients With Advanced Gastrointestinal Cancer in Relationship to Opioid Use: Findings From Eight Clinical Trials.
Abdel-Rahman O; Karachiwala H; Easaw JC
J Natl Compr Canc Netw; 2020 May; 18(5):575-581. PubMed ID: 32380454
[TBL] [Abstract][Full Text] [Related]
2. Vitamin and herbal supplements' use among patients with advanced gastrointestinal cancers included in eight clinical trials.
Abdel-Rahman O; Spratlin J; Koski S
J Cancer Res Clin Oncol; 2020 Aug; 146(8):2089-2097. PubMed ID: 32227265
[TBL] [Abstract][Full Text] [Related]
3. ECOG performance score 0 versus 1: impact on efficacy and safety of first-line 5-FU-based chemotherapy among patients with metastatic colorectal cancer included in five randomized trials.
Abdel-Rahman O
Int J Colorectal Dis; 2019 Dec; 34(12):2143-2150. PubMed ID: 31732876
[TBL] [Abstract][Full Text] [Related]
4. Impact of age on toxicity and efficacy of 5-FU-based combination chemotherapy among patients with metastatic colorectal cancer; a pooled analysis of five randomized trials.
Abdel-Rahman O; Karachiwala H
Int J Colorectal Dis; 2019 Oct; 34(10):1741-1747. PubMed ID: 31492988
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of metastatic colorectal cancer patients in relationship to prior and concurrent antibiotics use; individual patient data analysis of three clinical trials.
Abdel-Rahman O; Ghosh S; Walker J
Clin Transl Oncol; 2020 Sep; 22(9):1651-1656. PubMed ID: 32008218
[TBL] [Abstract][Full Text] [Related]
6. Effect of Body Mass Index on 5-FU-Based Chemotherapy Toxicity and Efficacy Among Patients With Metastatic Colorectal Cancer; A Pooled Analysis of 5 Randomized Trials.
Abdel-Rahman O
Clin Colorectal Cancer; 2019 Dec; 18(4):e385-e393. PubMed ID: 31378656
[TBL] [Abstract][Full Text] [Related]
7. Impact of Time From Diagnosis to Treatment Start on the Outcomes of Patients With Nonmetastatic Anal Squamous Cell Carcinoma.
Abdel-Rahman O; Ghosh S
Am J Clin Oncol; 2023 Jan; 46(1):31-35. PubMed ID: 36453694
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Baseline ALBI Score Among Patients With Colorectal Liver Metastases: A Pooled Analysis of Two Randomized Trials.
Abdel-Rahman O
Clin Colorectal Cancer; 2019 Mar; 18(1):e61-e68. PubMed ID: 30348618
[TBL] [Abstract][Full Text] [Related]
9. Effects of Intraoperative Opioid Use on Recurrence-Free and Overall Survival in Patients With Esophageal Adenocarcinoma and Squamous Cell Carcinoma.
Du KN; Feng L; Newhouse A; Mehta J; Lasala J; Mena GE; Hofstetter WL; Cata JP
Anesth Analg; 2018 Jul; 127(1):210-216. PubMed ID: 29757780
[TBL] [Abstract][Full Text] [Related]
10. Exposure to weak opioids and risk of gastrointestinal tract cancers: A series of nested case-control studies.
Houston MG; McMenamin Ú; Johnston B; McDowell RD; Hughes CM; Murchie P; Cardwell CR
Br J Clin Pharmacol; 2023 Sep; 89(9):2757-2766. PubMed ID: 37117154
[TBL] [Abstract][Full Text] [Related]
11. Impact of socioeconomic status on presentation, treatment and outcomes of patients with pancreatic cancer.
Abdel-Rahman O
J Comp Eff Res; 2020 Dec; 9(17):1233-1241. PubMed ID: 33275039
[No Abstract] [Full Text] [Related]
12. Comparison of survival between adolescent and young adult
Ren J; Tong YM; Cui RX; Wang Z; Li QL; Liu W; Qu K; Zhang JY; Liu C; Wan Y
World J Gastrointest Oncol; 2020 Dec; 12(12):1394-1406. PubMed ID: 33362910
[TBL] [Abstract][Full Text] [Related]
13. Astrocyte Elevated Gene-1 as a Novel Clinicopathological and Prognostic Biomarker for Gastrointestinal Cancers: A Meta-Analysis with 2999 Patients.
Luo Y; Zhang X; Tan Z; Wu P; Xiang X; Dang Y; Chen G
PLoS One; 2015; 10(12):e0145659. PubMed ID: 26710214
[TBL] [Abstract][Full Text] [Related]
14. Impact of Sex on Chemotherapy Toxicity and Efficacy Among Patients With Metastatic Colorectal Cancer: Pooled Analysis of 5 Randomized Trials.
Abdel-Rahman O
Clin Colorectal Cancer; 2019 Jun; 18(2):110-115.e2. PubMed ID: 30679026
[TBL] [Abstract][Full Text] [Related]
15. Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer.
Zylla D; Gourley BL; Vang D; Jackson S; Boatman S; Lindgren B; Kuskowski MA; Le C; Gupta K; Gupta P
Cancer; 2013 Dec; 119(23):4103-10. PubMed ID: 24104703
[TBL] [Abstract][Full Text] [Related]
16. Impact of cytoreductive surgery on outcomes of metastatic appendiceal carcinoma: a real-world, population-based study.
Abdel-Rahman O
J Comp Eff Res; 2020 Apr; 9(6):431-439. PubMed ID: 32253936
[No Abstract] [Full Text] [Related]
17. Prognosis of Hepatocellular Carcinoma Among Cancer Survivors with Other Types of Primary Tumors.
Bian X; He X; Yang L; Wu W; Li L
Dig Dis Sci; 2020 Jul; 65(7):2140-2147. PubMed ID: 31673904
[TBL] [Abstract][Full Text] [Related]
18. Statin treatment and outcomes of metastatic pancreatic cancer: a pooled analysis of two phase III studies.
Abdel-Rahman O
Clin Transl Oncol; 2019 Jun; 21(6):810-816. PubMed ID: 30465184
[TBL] [Abstract][Full Text] [Related]
19. Clinical Outcomes of Patients With Gastrointestinal Malignancies Participating in Phase I Clinical Trials.
Denson A; Burke N; Wapinsky G; Bertels B; Juan TH; Lee J; Springett GM; Strosberg JR; Kim RD; Sullivan DM; Mahipal A
Am J Clin Oncol; 2018 Feb; 41(2):133-139. PubMed ID: 26523441
[TBL] [Abstract][Full Text] [Related]
20. Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients With Oral Cavity Cancer.
Ding D; Stokes W; Eguchi M; Hararah M; Sumner W; Amini A; Goddard J; Somerset H; Bradley C; McDermott J; Raben D; Karam SD
JAMA Otolaryngol Head Neck Surg; 2019 Jan; 145(1):53-61. PubMed ID: 30452499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
